R&D expense · 2011–2025
Acadia Pharmaceuticals R&D expense
$329M+8.4% · FY2025
Acadia Pharmaceuticals (ACAD) reported $329M in R&D expense for fiscal 2025, +8.4% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $329M | +8.4% | Open → |
| FY20242024-12-31 | $303M | −13.8% | Open → |
| FY20232023-12-31 | $352M | −2.8% | Open → |
| FY20222022-12-31 | $362M | +51.0% | Open → |
| FY20212021-12-31 | $239M | −25.0% | Open → |
| FY20202020-12-31 | $319M | +32.8% | Open → |
| FY20192019-12-31 | $240M | +28.4% | Open → |
| FY20182018-12-31 | $187M | +25.5% | Open → |
| FY20172017-12-31 | $149M | +50.3% | Open → |
| FY20162016-12-31 | $99.3M | +34.4% | Open → |
| FY20152015-12-31 | $73.9M | +21.9% | Open → |
| FY20142014-12-31 | $60.6M | +126.8% | Open → |
| FY20132013-12-31 | $26.7M | +42.2% | Open → |
| FY20122012-12-31 | $18.8M | +8.6% | Open → |
| FY20112011-12-31 | $17.3M | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +23.4%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Acadia Pharmaceuticals R&D expense |url=https://companiesranked.com/en/company/acadia-pharmaceuticals/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Acadia Pharmaceuticals R&D expense. CompaniesRanked. https://companiesranked.com/en/company/acadia-pharmaceuticals/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-acadia-pharmaceuticals-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Acadia Pharmaceuticals R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/acadia-pharmaceuticals/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-072519 · February 26, 2026
{{cite web |title=Acadia Pharmaceuticals R&D expense — 10-K (0001193125-26-072519) |url=https://www.sec.gov/Archives/edgar/data/1070494/000119312526072519/acad-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.